Blood glucose testing for adults prescribed atypical antipsychotics in primary and secondary care

Psychiatric Bulletin

Volumn 30, Issue 8, 2006, Pages 286-288

  Tarrant, Catharine Jane ^a  

^a Sutton Health Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; GLUCOSE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; COMMUNITY; CONSENSUS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MENTAL DISEASE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; RURAL AREA; STANDARD; TREATMENT DURATION;

EID: 33747323389     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.30.8.286     Document Type: Article

References (17)

1. BOILSON, M. & HAMILTON, B. J. (2003) A survey of monitoring of weight and blood glucose in in-patients. Psychiatric Bulletin, 27, 424-426.
2. BRITISH MEDICAL ASSOCIATION (2004) Quality and Outcomes Framework Guidance. Section 2: Clinical Indicators. Mental Health. London: BMA. http://www.bma.org.uk/ap.nsf/Content/QualityOutcomes~clinical~mh
3. BUSHE, C. & HOLT, R. (2004) Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia. British Journal of Psychiatry, 84(suppl. 47), s67-s71.
4. CITROME, L., JAFFE, A., LEVINE, J., et al (2004) Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric in-patients. Psychiatric Services, 55, 1006-1013.
5. CONNOLLY, M. & KELLY, C. (2005) Lifestyle and physical health in schizophrenia. Advances in Psychiatric Treatment, 11, 125-132.
6. EXPERT GROUP (2004) 'Schizophrenia and Diabetes 2003' Expert Consensus Meeting, Dublin 3-4 October 2003: consensus summary. British Journal of Psychiatry, 184 (suppl. 47), s112-s114.
7. HADDAD, P. M. (2004) Antipsychotics and diabetes: review of nonprospective data. British Journal of Psychiatry, 184 (suppl. 74), s80-s86.
8. HAUPT, D.W. & NEWCOMER, J.W. (2001) Hyperglycaemia and antipsychotic medications. Journal of Clinical Psychiatry, 62 (suppl. 27), 15-26.
9. HOWES, O. D., BHATNAGAR, A., GAUGHRAN, E. P., et al (2004) A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance. American Journal of Psychiatry, 161, 361-363.
10. KORO, C. E., FEDDER, D. O., L'ITALIEN, G. J., et al (2002) Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-contro study. BMJ, 325, 243-248.
11. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (2002a) Management of Type 2 Diabetes - Managing Blood Glucose Levels (Guideline G). http:// www.nice.org.uk/page.aspx?o=36737
12. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (2002b) The Clinical Effectiveness and Cost Effectiveness of Newer Atypical Antipsychotic Drugs for Schizophrenia (Technology Appraisal 43). http:// www.nice.org.uk/page.aspx?o=ta043
13. NEWCOMER, J. W., HAUPT, D. W., FUCETOLA, R., et al (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Archives of General Psychiatry, 59, 337-345.
14. SMITH, H. & WHITE, T. (2004) Low glycaemic index diet in patients prescribed clozapine: pilot study. Psychiatric Bulletin, 28, 292-294.
15. TAYLOR, D., PATTON, C. & KERWIN, R. (2003) The Maudsley 2003 Prescribing Guidelines. (7th edn). London: Martin Dunitz.
16. TAYLOR, D., YOUNG, C., ESOP, R., et al (2004) Testing for diabetes in hospitalised patients prescribed antipsychotic drugs. British Journal of Psychiatry, 185, 152-156.
17. WORLD HEALTH ORGANIZATION (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.